Message from the President
There has been a convergence of technologies around stem cell research that are dramatically increasing our understanding of developmental biology, human disease, and how to regenerate damaged tissue. Cutting edge technological advancements in computational biology, machine learning, single cell sequencing, gene editing, and organoids are being harnessed by stem cell researchers to accelerate their discoveries and move them towards the clinic. These revolutionary advances will be in the spotlight from 24-27 June, 2020, at the largest stem cell meeting in the world— the ISSCR 2020 Annual Meeting in Boston, U.S.Full story
- 10 December, 2019
Stem cell science, its clinical application, and the ethical issues surrounding it have rapidly advanced since the release of the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation. The latest update will address important scientific, ethical, and regulatory issues, including embryo models, organoids, chimeras, genome editing, and the regulation and economics of cell therapies.Full story
- 9 December, 2019
Gladstone Institutes, U.S.
ISSCR 2020 Boston: From Cutting Edge Technology to Clinical Trials
There has been a convergence of technologies around stem cell research that are dramatically increasing our understanding of developmental biology, human disease, and how to regenerate damaged tissue. Cutting edge technological advancements in computational biology, machine learning, single cell sequencing, gene editing, and organoids are being harnessed by stem cell researchers to accelerate their discoveries and move them towards the clinic. These revolutionary advances will be in the spotlight at the ISSCR 2020 Annual Meeting in Boston, USA.
Communicating About Unproven Stem Cell Treatments to the Public
Stem Cells in the News
Media highlights in the field of stem cell research and its translation to the clinic.
8 August, Stem Cell Xpress
CRISPR Gene Editing Is Being Tested in Human Patients, and the Results Could Revolutionize Health Care
6 August, Time
3 August, The Guardian
A sampling of recent stem cell research commentaries, articles, and resources.
On the cover: Cover In this issue, Wnorowski and Sharma et al. demonstrate that human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) cultured aboard the International Space Station exhibit alterations in cellular function and gene expression during spaceflight. The space station image is overlaid with an immunofluorescence image of hiPSC-CMs, described in Wnorowski and Sharma et al. Cardiomyocytes are stained with the nuclear marker DAPI (blue) and the sarcomere markers alpha-actinin (green) and cardiac troponin T (red). Images were provided by Alexa Wnorowski, Arun Sharma, Joseph Wu, and the National Aeronautics and Space Administration (NASA).
Featured Current Protocols in Stem Cell Biology Article
A High-Throughput Screening Method to Identify Compounds Displaying Human Vascular Embryonic Toxicity, Rose et al. (2019), Current Protocols in Stem Cell Biology, 50, e93. doi: 10.1002/cpsc.93.
Induced 2C Expression and Implantation-Competent Blastocyst-Like Cysts From Primed Pluripotent Stem Cells, Kime et al (2019), Stem Cell Reports. doi:10.1016/j.stemcr.2019.07.011.
- , Shanghai
Seeking a job? Have a job opening? the ISSCR Job Board gives members discounts on job postings here and in the monthly Pulse e-newsletter.
Other Stem Cell Events
Opportunities for researchers from around the world to explore the latest discoveries in stem cell science and regenerative medicine.
Global Policy News
ISSCR and policy news from around the world.
25 July, Regulatory Focus
As Stem Cell Clinics Proliferate, Energy and Commerce Leaders Seek to Hear FDA’s Plan
26 July, Science
Trump Administration Releases Details on Fetal Tissue Restrictions
3 August, The Guardian
FDA First Human-Monkey Chimera Raises Concern Among Scientists
Learn about ISSCR colleagues in the stem cell field from around the world.
Kirstin Matthews, PhD
Havre de Grace, Maryland, USA
Houston, Texas, USA
Ph.D., The University of Texas Health Science Center at Houston
Fellow in Science and Technology Policy at Rice University’s Baker Institute for Public Policy